Kinnate Biopharma Inc.

NasdaqGS:KNTE Stock Report

Market Cap: US$125.1m

Kinnate Biopharma Inc. Company Information

Kinnate Biopharma Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Kinnate Biopharma Inc.
  • Ticker: KNTE
  • Exchange: NasdaqGS
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$125.147m
  • Shares Outstanding: 47.23m
  • Website: https://www.kinnate.com

Number of Employees

Location

  • Kinnate Biopharma Inc.
  • 103 Montgomery Street
  • Suite 150
  • San Francisco
  • California
  • 94129
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6KBMUN (Boerse Muenchen)YesCommon StockDEEURDec 2020
KNTENasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDDec 2020
6KBDB (Deutsche Boerse AG)YesCommon StockDEEURDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/03 05:00
End of Day Share Price 2024/04/03 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.